|
US8507498B2
(en)
*
|
2007-04-24 |
2013-08-13 |
Ingenium Pharmaceuticals Gmbh |
4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
|
|
US8436007B2
(en)
|
2007-04-24 |
2013-05-07 |
Ingenium Pharmaceuticals Gmbh |
Inhibitors of protein kinases
|
|
WO2008129069A1
(en)
*
|
2007-04-24 |
2008-10-30 |
Ingenium Pharmaceuticals Gmbh |
Inhibitors of protein kinases
|
|
US20120177761A1
(en)
|
2009-07-08 |
2012-07-12 |
Chien-Wei Hou |
Method of making longan seed extract
|
|
JP2013107824A
(ja)
*
|
2010-03-17 |
2013-06-06 |
Dainippon Sumitomo Pharma Co Ltd |
新規単環ピリミジン誘導体
|
|
EP2550257B1
(en)
*
|
2010-03-22 |
2016-12-21 |
Lead Discovery Center GmbH |
Pharmaceutically active disubstituted triazine derivatives
|
|
WO2012066065A1
(en)
*
|
2010-11-17 |
2012-05-24 |
Novartis Ag |
Phenyl-heteroaryl amine compounds and their uses
|
|
EP2681193B1
(en)
|
2011-03-02 |
2016-01-06 |
Lead Discovery Center GmbH |
Pharmaceutically active disubstituted pyridine derivatives
|
|
US9226929B2
(en)
|
2011-03-02 |
2016-01-05 |
Bayer Intellectual Property Gmbh |
Pharmaceutically active disubstituted triazine derivatives
|
|
ES2613103T3
(es)
*
|
2011-04-19 |
2017-05-22 |
Bayer Intellectual Property Gmbh |
4-Aril-n-fenil-1,3,5-triacin-2-aminas sustituidas
|
|
TWI555737B
(zh)
|
2011-05-24 |
2016-11-01 |
拜耳知識產權公司 |
含有硫醯亞胺基團之４－芳基－ｎ－苯基－１，３，５－三氮雜苯－２－胺
|
|
EP2527332A1
(en)
|
2011-05-24 |
2012-11-28 |
Bayer Intellectual Property GmbH |
4-Aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group as CDK9 inhibitors
|
|
US9108926B2
(en)
*
|
2011-09-16 |
2015-08-18 |
Bayer Intellectual Property Gmbh |
Disubstituted 5-fluoro-pyrimidines
|
|
EP2755948B1
(en)
|
2011-09-16 |
2016-05-25 |
Bayer Intellectual Property GmbH |
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group
|
|
CN105102434A
(zh)
*
|
2012-10-18 |
2015-11-25 |
拜耳药业股份公司 |
含砜基团的4-(邻)-氟苯基-5-氟嘧啶-2-基胺
|
|
HK1209414A1
(en)
*
|
2012-10-18 |
2016-04-01 |
Bayer Pharma Aktiengesellschaft |
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
|
|
ES2616441T3
(es)
|
2012-10-18 |
2017-06-13 |
Bayer Pharma Aktiengesellschaft |
Derivados de N-(piridin-2-il))pirimidin-4-amina que contienen un grupo sulfona
|
|
TW201418243A
(zh)
|
2012-11-15 |
2014-05-16 |
Bayer Pharma AG |
含有磺醯亞胺基團之ｎ－（吡啶－２－基）嘧啶－４－胺衍生物
|
|
US9499492B2
(en)
*
|
2012-11-15 |
2016-11-22 |
Bayer Pharma Aktiengesellschaft |
4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine group
|
|
AU2013346939B2
(en)
|
2012-11-15 |
2017-06-08 |
Bayer Pharma Aktiengesellschaft |
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
|
|
ES2630115T3
(es)
|
2013-07-04 |
2017-08-18 |
Bayer Pharma Aktiengesellschaft |
Derivados de 5-fluoro-n-(piridin-2-il)piridin-2-amina con sulfoximina sustituida y su uso como inhibidores de quinasa cdk9
|
|
EP3116869A1
(en)
|
2014-03-13 |
2017-01-18 |
Bayer Pharma Aktiengesellschaft |
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
|
|
CN106414412B
(zh)
*
|
2014-04-01 |
2019-06-21 |
拜耳医药股份有限公司 |
含有磺酰二亚胺基团的二取代的5-氟嘧啶衍生物
|
|
CR20160471A
(es)
|
2014-04-11 |
2016-12-21 |
Bayer Pharma AG |
Compuestos novedosos macrocíclicos
|
|
CA2964683A1
(en)
|
2014-10-16 |
2016-04-21 |
Bayer Pharma Aktiengesellschaft |
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfone group
|
|
CA2964696C
(en)
|
2014-10-16 |
2022-09-06 |
Bayer Pharma Aktiengesellschaft |
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfoximine group
|
|
WO2016150903A1
(en)
|
2015-03-24 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating lymphomas
|
|
EP3274338A1
(en)
|
2015-03-24 |
2018-01-31 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating multiple myeloma
|
|
WO2016150902A1
(en)
|
2015-03-24 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating gastric cancers
|
|
PH12017502334B1
(en)
|
2015-06-29 |
2023-05-26 |
Astrazeneca Ab |
Polycyclic amide derivative as cdk9 inhibitors
|
|
CA2999931A1
(en)
|
2015-09-29 |
2017-04-06 |
Bayer Pharma Aktiengesellschaft |
Novel macrocyclic sulfondiimine compounds
|
|
JP6888000B2
(ja)
|
2015-10-08 |
2021-06-16 |
バイエル ファーマ アクチエンゲゼルシャフト |
新規な修飾された大環状化合物
|
|
WO2017060322A2
(en)
|
2015-10-10 |
2017-04-13 |
Bayer Pharma Aktiengesellschaft |
Ptefb-inhibitor-adc
|
|
EP3601236A1
(en)
|
2017-03-28 |
2020-02-05 |
Bayer Aktiengesellschaft |
Novel ptefb inhibiting macrocyclic compounds
|
|
ES2900199T3
(es)
|
2017-03-28 |
2022-03-16 |
Bayer Ag |
Novedosos compuestos macrocíclicos inhibidores de PTEFB
|
|
US11701347B2
(en)
|
2018-02-13 |
2023-07-18 |
Bayer Aktiengesellschaft |
Use of 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(S-methylsulfonimidoyl)methyl]pyridin-2-yl}pyridin-2-amine for treating diffuse large B-cell lymphoma
|
|
CN115335058B
(zh)
*
|
2020-03-27 |
2024-12-06 |
国立大学法人京都大学 |
神经细胞变性抑制剂
|